Navigation Links
Migraine Research Foundation Announces Winners of 2009 Research Grants
Date:9/5/2009

The Migraine Research Foundation today announced the winners of the 2009 research grants. This year's grantees will explore such important areas as pediatric migraine, the genetic association between migraine and cardiovascular events, and why opioids enhance migraine pain.

(PRWEB) September 5, 2009 -- The Migraine Research Foundation (MRF), the only nonprofit organization devoted solely to funding migraine research, today announced the winners of the 2009 research grants. This year's grantees will explore such important areas as pediatric migraine, the genetic association between migraine and cardiovascular events, and why opioids enhance migraine pain.

The six grants, totaling $300,000, were selected by MRF and its distinguished medical advisory board from an unprecedented 34 proposals from 5 countries. "We were delighted with the depth and breadth of the work represented by these proposals. This is a testament to the enthusiasm and intellect of our researchers today," said Cathy Glaser, co-founder and President of MRF. "To date, we've given $700,000 to some of the most promising investigators to move the science of migraine forward - and we know they're going to make a difference."

Migraine affects more than 30 million Americans - nearly 1 in 4 households - and ranks in the top 20 of the world's most disabling medical illnesses. Yet despite the widespread prevalence and the serious effects on individuals, family and society, research into its causes and treatments is sorely lacking. MRF provides annual research grants to scientists to explore new avenues in migraine and to encourage new researchers to enter the field.

The six MRF grant recipients and their research are:

 
  • Yu-Qing Cao, Ph.D, Washington University Pain Center, St. Louis, MO
The Effects of Calcium Channel Mutations on Trigeminal Ganglion Neurons Innervating the Dura

 
  • Teresa Esposito, Ph.D, Institute of Genetics and Biophysics, Naples, Italy
The Role of Ionotropic Glutamate Receptor Genes in Migraine

 
  • Golda Ginsburg, Ph.D, Johns Hopkins School of Medicine, Baltimore, MD
A Pilot Study of Family-Based Cognitive Behavioral Therapy for Treating Chronic Pediatric Headache/Migraine and Comorbid Anxiety

 
  • Richard Kraig, MD, Ph.D, University of Chicago Medical Center, Chicago, IL
Microglia and Cytokines Modulate Chronic Migraine

 
  • Markus Schürks, MD, MSc & Tobias Kurth, MD, ScD, Brigham and Women's Hospital, Boston, MA
Identification of Genetic Determinants of the Association Between Migraine and Cardiovascular Events: A Genome-Wide Association Study

 
  • Julie Wieseler, Ph.D & Linda Watkins, Ph.D, University of Colorado at Boulder, Boulder, CO
Why Opioids Enhance Migraine Pain: The Puzzle Points to Glia

"This year's recipients continue to demonstrate the highly innovative thinking which MRF has encouraged since its founding. The medical community is grateful to the foundation and the investigators it supports," said Dr. Joel Saper, founder of the Michigan Head Pain & Neurological Institute, Ann Arbor, MI, and Chair of MRF's medical advisory board.    

The MRF medical advisory board of distinguished scientists, chaired by Dr. Saper, also includes Dr. Rami Burstein (Harvard Medical School, Boston, MA), Dr. F. Michael Cutrer (Mayo Clinic, Rochester, MN), Dr. David W. Dodick (Mayo Clinic, Phoenix, AZ and President-Elect of the American Headache Society), Dr. Peter J. Goadsby (University of California at San Francisco, CA), Dr. Richard Lipton (Albert Einstein College of Medicine, Bronx, NY), Dr. Fred Sheftell (New England Center for Headache, Stamford, CT and President of the American Headache Society), and Dr. Stephen D. Silberstein (Jefferson University Hospital, Philadelphia, PA).

About the Migraine Research Foundation
The Migraine Research Foundation is a nonprofit 501(c)(3) organization dedicated to ending the debilitating pain of migraine by funding research into its causes, better treatment options and ultimately, to find a cure. More information about MRF and how to contribute can be found at migraineresearchfoundation.org

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2836674.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Migraine Drug Shows Promise
2. Jefferson Headache Center study shows novel, orally inhaled migraine therapy effective
3. Latest Holiday Migraine Survey Results Published
4. While Some New Agents Will Achieve Strong Sales, the Migraine Drug Market Will Decline $1.3 Billion by 2018 as Generic Erosion Takes Toll on Top-Selling Brands
5. Plastic Surgery Technique Might Ease Migraines
6. Migraines Linked to Reduced Breast Cancer Risk
7. Link between migraines and reduced breast cancer risk confirmed in follow-up study
8. Migraine Frequency Tied to Stroke, Heart Attack Risk
9. Smoking more than 5 cigarettes a day provokes migraine attacks
10. Migraine With Aura May Lead to Brain Lesions
11. Common migraine pain condition also prevalent in cluster headache
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... , ... Japanese Zen artist couple, Fumie and Kentaro Mune, have announced to ... at Miranda Kuo Gallery on Lower East Side, NYC. This exhibition will feature some ... Wanderlust , one of the largest US yoga online media outlets in the world, ...
(Date:9/21/2017)... ... 2017 , ... FlipBelt, the fitness brand that specializes in problem solving fitness ... market with the launch of their FlipBelt Crops. , The new fitness bottoms feature ... fingertips while at the gym, on the trail, or on-the-go. , “We always thought ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... offices serving communities in northern Alabama and Georgia, is embarking on an extended ... by utilizing modern early detection methods. , US Breast Cancer statistics show ...
(Date:9/20/2017)... ... 20, 2017 , ... Reflections Recovery Center, a men-only drug ... Joint Commission for chemical dependency and behavioral health services. , The Joint Commission ... that meet the commission’s rigorous standards. Accreditation by The Joint Commission is the ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... Plus Coating System for clients that rely on safety and cleanliness. This unique ... microorganisms. , Silver has been used for centuries for its antimicrobial properties. Unlike ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017   PDI , a leader ... will host an educational session focused on the role ... (CLABSI) prevention at the 2017 Annual Scientific Meeting of ... take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s Prevantics® ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: LLY ) ... and lasmiditan, two investigational treatments for migraine, at the ... place Sept. 7-10 in Vancouver . ... from an open-label study evaluating the safety and effectiveness ... mg) for the prevention of migraine. Galcanezumab is a ...
(Date:9/5/2017)... , Sept. 5, 2017  Xyntek Inc. has announced another milestone in their ... Midwest office to meet the growing demands of customer engagements regionally.  ... Xyntek's new Midwest office is located at 318 West Adams ... ... engagements regionally. ...
Breaking Medicine Technology: